ABBOTT LABORATORIES — Director's Dealing 2017

Oct 4, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-10-01

Reporting Person: Wellisch Alejandro D (Senior Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	10956	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$50.72	2027-07-20	Common shares (15339)		Direct
Option (right to buy)	$50.72	2027-07-20	Common shares (15338)		Direct
Option (right to buy)	$50.72	2027-07-20	Common shares (15339)		Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.